• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    EchoNous Partners with Samsung

    Solid Growth Forecast for Global Ostomy Devices Market

    KA Imaging's Reveal 35C Images Increase Lung Lesion Visibility

    Respira Technologies Appoints Brian Quigley as CEO

    Nikki Troiano Gainey Joins RIVANNA Board
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Concise Engineering

    JBC Technologies

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Buyer and Seller Tips on Mergers & Acquisitions for MPO Companies

    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Concise Engineering

    JBC Technologies

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Implanted Drug ‘Reservoir’ Safely Reduces Injections for Macular Degeneration Patients

    Implanting a medication reservoir in eyes lessens the need for injections and may reduce clinic visits to twice per year.

    Implanted Drug ‘Reservoir’ Safely Reduces Injections for Macular Degeneration Patients
    Port Delivery System. Image courtesy of Genetech.
    Related CONTENT
    • Industry Events Schedule Disrupted Due to Coronavirus—Full Event List
    • AtriCure Enrolls First Patient in the DEEP IDE Trial Restart
    • New Blood Test Uses DNA ‘Packaging’ Patterns to Detect Multiple Cancer Types
    • Implandata Gains CE Mark for Next-Generation EyeMate System
    • Alcon Debuts as an Independent Company
    Johns Hopkins Medicine06.14.19
    In a clinical trial of 220 people with “wet” age-related macular degeneration, Johns Hopkins Medicine researchers, collaborators from many sites across the country, and Genentech in South San Francisco have added to evidence that using a new implant technology that continuously delivers medication into the eyes is safe and effective in helping maintain vision and reduces the need for injections in the eyes.
     
    The investigators note that research is needed on larger groups of patients before the implant can be approved for commercial availability and use.
     
     “Current treatment programs require frequent visits to the doctor, commonly every four to six weeks, for injections of medication. Missed appointments, which are common, can lead to an irreversible decline in vision, “ said Peter Campochiaro, M.D., the George S. and Dolores D. Eccles Professor in Ophthalmology at the Wilmer Eye Institute at Johns Hopkins. “This study shows that the implant is safe and effective, and may only require a clinic visit and refill every six months.”
     
    The research findings were published online April 1 in the journal Ophthalmology.
     
    According to the National Eye Institute, some 8 million adults over age 50 in the United States have age-related macular degeneration (AMD), a progressive condition marked by the loss of central vision and permanent damage to cells in the light-sensitive retina. The advanced, or so-called wet, form of AMD is a major cause of blindness in 1.75 million elderly Americans. In these people, a buildup of debris in the retina triggers the overproduction of a growth factor called vascular endothelial growth factor (VEGF), which stimulates overgrowth of blood vessels that leak, causing swelling and—if untreated—scarring of the retina. Like pouring water on electrical wires, the process interferes with the neural network that enables sight, causing vision to blur.
     
    Although no therapies are available to cure the condition, several drugs suppress VEGF and slow the disease progression when injected directly into the eye. The treatments, Campochiaro notes, help preserve central vision but only temporarily, partly because the drugs’ effect is not long lasting. Even monthly injections may show relatively rapid swings in the level of retina swelling due to stopping and then restarting of leakage from blood vessels.
     
    In an effort to keep drug levels more steady, investigators have been testing the value of a port delivery system, a reservoir that is implanted in patients’ eyes through a small incision and slowly releases medication over time.
     
    When the reservoir is implanted, physicians can replenish the medication without removing the reservoir.
     
    To test the technology’s effectiveness and safety, researchers recruited 220 patients with wet-form AMD from 49 sites across the U.S. over a two-year period from Sept. 29, 2015, to Sept. 5, 2017. The mean age of patients was 73.8, with a range of 50 to 92 years, and 64.1 percent were female. The majority of patients were white (97.7 percent); 0.9 percent were American Indian and 0.5 percent were African American.
     
    Each patient had the implant in one eye and was tracked with measurements of vision, fluid in the retina, safety and side effects each month for nine to 38 months after implantation.
     
    Researchers filled the reservoir with 10 milligrams per milliliter of medication in 58 patients, 40 milligrams per milliliter of medication in 62 patients, and 100 milligrams per milliliter of medication in 59 patients. For comparison, they followed a control group of 41 patients who received the traditional treatment of a monthly injection of 0.5 milligram of medication.
     
    During each visit, ophthalmologists assessed the severity of retinal swelling, the patient’s eyesight and development of new macular bleeding to assess the need for reservoir refills.
     
    On average, patients who were implanted with the reservoir filled with 100 milligrams per millimeter of medication did not require a refill until 15 months after implantation, and about 80 percent of patients with this dosage went beyond six months before needing a refill.
     
    Researchers also say there was a significant average improvement in the eyesight of patients with 100 milligrams per millimeter of medication. At the starting point, the average vision for the patients was being able to see, standing 20 feet from an eye chart, what an average person can see 40 feet away from the eye chart. After nine months of treatment, these patients could see an average of five more letters—at 20 feet away from the eye chart, they could see what an average person can see 32 feet away.
     
    In comparison, patients with the reservoir of 10 milligrams per millimeter of medication and 40 milligrams per millimeter of medication could see 3.2 and 0.5 fewer eye chart letters respectively compared to baseline, and the average times to first implant refill were 8.7 months and 13 months respectively. Patients treated with traditional monthly injection could see an average of 3.9 more letters than during their initial appointment during the study.
     
    Besides improving eyesight, the technology was safe for patients. Eleven of the first 22 patients experienced some bleeding into the eye after implantation, leading to a change in the implant procedure, after which only seven of 157 experienced bleeding.
     
    Studies are planned with a larger group of patients receiving implants with a reservoir holding the 100 milligram per milliliter dosage. Campochiaro said the cost of the implant is not yet known, but over time, it is likely to be less than that of monthly injections, which currently is about $2,000 per injection.
     
    Campochiaro said other treatments that provide sustained suppression of VEGF, such as gene therapy, are also being tested in clinical trials, and results will be available by the end of the year.
     
    Other authors of the study include Dennis Marcus, M.D., from the Southeast Retina Center, Augusta, Georgia; Carl Awh, M.D., from Tennessee Retina, Nashville, Tennessee; Carl Regillo, M.D., from Wills Eye Hospital, Philadelphia, Pennsylvania;  and Anthony Adamis, M.D., Vladimir Bantseev, Ph.D., Yawen Chiang, Ph.D., Jason Ehrlich, M.D., Ph.D., Signe Erickson, Ph.D., William Hanley, Ph.D., Joshua Horvath, Ph.D., Katie Maass, Ph.D., Natasha Singh, Pharm.D., Fan Tang, Ph.D., and Giulio Barteselli, M.D., from Genentech, South San Francisco, California.
     
    Genentech provided support for the study and participated in the study design, conducting the study and data collection, management and interpretation. Third-party writing assistance was provided by Betsy Taylor, Ph.D., of Envision Pharma Group and funded by Genentech.
    Related Searches
    • development
    • therapy
    • institute
    • 2015
    Suggested For You
    Industry Events Schedule Disrupted Due to Coronavirus—Full Event List Industry Events Schedule Disrupted Due to Coronavirus—Full Event List
    AtriCure Enrolls First Patient in the DEEP IDE Trial Restart AtriCure Enrolls First Patient in the DEEP IDE Trial Restart
    New Blood Test Uses DNA ‘Packaging’ Patterns to Detect Multiple Cancer Types New Blood Test Uses DNA ‘Packaging’ Patterns to Detect Multiple Cancer Types
    Implandata Gains CE Mark for Next-Generation EyeMate System Implandata Gains CE Mark for Next-Generation EyeMate System
    Alcon Debuts as an Independent Company Alcon Debuts as an Independent Company
    Ocutrx Vision Technologies Unveils Oculenz AR Cellular with Eye-Tracking Glasses Design Ocutrx Vision Technologies Unveils Oculenz AR Cellular with Eye-Tracking Glasses Design
    FemPulse Announces Enrollment in Multi-Center EVANESCE-OAB Study FemPulse Announces Enrollment in Multi-Center EVANESCE-OAB Study
    Early Detection, Home Monitoring Tests for Lupus Nephritis Under Development Early Detection, Home Monitoring Tests for Lupus Nephritis Under Development
    First Patient Treated for Severe Emphysema with Olympus First Patient Treated for Severe Emphysema with Olympus' Spiration Valve System
    Medality Medical Receives FDA IDE Approval for Reversal of Type 2 Diabetes Clinical Trial Medality Medical Receives FDA IDE Approval for Reversal of Type 2 Diabetes Clinical Trial
    GI Dynamics Announces Institutional Review Board Approval for EndoBarrier Pivotal Trial GI Dynamics Announces Institutional Review Board Approval for EndoBarrier Pivotal Trial
    Hydrogel Contact Lens Could Treat Serious Eye Disease Hydrogel Contact Lens Could Treat Serious Eye Disease
    Presbia Achieves ISO 3485 Certification Presbia Achieves ISO 3485 Certification
    FDA Awards Breakthrough Status to Blood Test to Determine Alzheimer FDA Awards Breakthrough Status to Blood Test to Determine Alzheimer's Risk
    FDA Clears Cook Medical & Zelegant FDA Clears Cook Medical & Zelegant's ElevoKit Snoring Intervention Device

    Related Breaking News

    • Industry Events Schedule Disrupted Due to Coronavirus—Full Event List

      Industry Events Schedule Disrupted Due to Coronavirus—Full Event List

      The medical device manufacturing industry has seen the postponement or cancellation of a number of upcoming events.
      Sean Fenske, Editor-in-Chief 03.30.20

    • Cardiovascular
      AtriCure Enrolls First Patient in the DEEP IDE Trial Restart

      AtriCure Enrolls First Patient in the DEEP IDE Trial Restart

      The study is intended to establish the safety and effectiveness of a dual epicardial and endocardial ablation procedure.
      Business Wire 06.07.19

    • New Blood Test Uses DNA ‘Packaging’ Patterns to Detect Multiple Cancer Types

      New Blood Test Uses DNA ‘Packaging’ Patterns to Detect Multiple Cancer Types

      The test could potentially detect the presence of seven different types of cancer.
      Johns Hopkins Medicine 05.31.19


    • Implandata Gains CE Mark for Next-Generation EyeMate System

      Implandata Gains CE Mark for Next-Generation EyeMate System

      Technology undergoing European market launch.
      B3C Newswire 05.06.19

    • Surgical
      Alcon Debuts as an Independent Company

      Alcon Debuts as an Independent Company

      Company completes separation from Novartis; began trading April 9 on SIX Swiss Exchange and NYSE.
      Business Wire 04.10.19

    Loading, Please Wait..

    Trending
    • Monkeypox Outbreak Driving New IVD Device Development
    • M1 MedTech Announces Fall 2022 Cohort
    • Preceptis Medical’s Tympanostomy Tube System Cleared For Expanded Indications
    • Pulsed Field Ablation Tech Gaining Popularity
    • Edwards' PASCAL Precision Gains EU Nod
    Breaking News
    • EchoNous Partners with Samsung
    • Solid Growth Forecast for Global Ostomy Devices Market
    • KA Imaging's Reveal 35C Images Increase Lung Lesion Visibility
    • Respira Technologies Appoints Brian Quigley as CEO
    • Nikki Troiano Gainey Joins RIVANNA Board
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    IFIC 2022 Food & Health Survey Highlights Eating Behavior Trends
    Icon Foods Appoints Operations and Marketing Leaders
    Annatto Tocotrienol Shown to Improve Weight Loss and Inflammation Markers in Patients with NAFLD
    Coatings World

    Latest Breaking News From Coatings World

    Birla Carbon, NREL Collaboration to be Presented at ACS Conference
    Coating Resins Market Worth $70.9 Billion by 2027: MarketsandMarkets
    PPG Appoints Brad Budde Vice President and Chief Digital Officer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    EchoNous Partners with Samsung
    Solid Growth Forecast for Global Ostomy Devices Market
    KA Imaging's Reveal 35C Images Increase Lung Lesion Visibility
    Contract Pharma

    Latest Breaking News From Contract Pharma

    GRAM to Fill and Finish Smallpox/Monkeypox Vaccines
    bluebird bio Wins FDA Approval of ZYNTEGLO
    Pace Life Sciences Acquires Meridian BioGroup
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Sephora at Kohl’s to Expand Sephora Presence to All 1,100+ Kohl’s Locations
    Emma Watson to Front New Fragrance Campaign for Prada
    The Estée Lauder Companies Delivers Strong Results in Fiscal 2022
    Happi

    Latest Breaking News From Happi

    Amorepacific, MIT Develop World's First Chip-less Wireless Electronic Skin Enabled by Semiconductors
    Maesa Launches Itk Skincare with TikTok Stars Brooklyn and Bailey McKnight
    Skin Delivery Formulation
    Ink World

    Latest Breaking News From Ink World

    Xeikon to Introduce TITON Food-Safe Dry-Toner Technology at Labelexpo Americas 2022
    Smurfit Kappa Employees Charity Cycle Across Europe
    ProAmpac’s Rocky Mount, VA Facility Receives ISCC Plus Certification
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ePac makes big announcement, Avery Dennison debuts new technology and more
    Techkon USA announces latest handheld spectrodensitometer
    Maxcess China now manufacturing solid dies in Huzhou
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    INDA Appoints Director of Membership and Industry Relations
    Nexwear Acquires Incontinence Products Brand Lily Bird
    Because Market Expands into Retail Stores
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Theragen Receives Patent for Spine Fusion Bone Growth Stimulator System
    Study: BONESUPPORT’s CERAMENT G Can Help Save Infected Limbs
    Zavation’s Cervical Intervertebral Body Fusion Device Cleared by FDA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    NREL, Birla Carbon Collaboration to be Shown at ACS Conference
    ORNL Celebrates Launch of Frontier, the World’s Fastest Supercomputer
    DuPont Names 2022 Lavoisier and Pedersen Award Medalists

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login